Total Shoulder Arthroplasty Clinical Trial
Official title:
Diagnostic Accuracy of Synovial Biopsy for Implant-Related Shoulder Infections
Verified date | April 2024 |
Source | Ottawa Hospital Research Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to determine the efficacy of retrieving tissue samples via an x-ray guided needle that is inserted into the infected tissue in the shoulder. The procedure using the guided needle is called a synovial biopsy versus an open tissue biopsy, which is done at the time of surgery. By doing the synovial biopsy prior to a revision surgery, the investigators hope to avoid more invasive intervention if it is not needed. Some patients may appear to have an infection but once the biopsy is taken and the results are read, there may not be an infection and therefore no need for a revision surgery.
Status | Active, not recruiting |
Enrollment | 118 |
Est. completion date | December 2027 |
Est. primary completion date | December 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility | Inclusion Criteria: 1. Previous shoulder surgery including hemiarthroplasty, total shoulder arthroplasty or reverse total shoulder arthroplasty, or internal fixation for shoulder fractures 2. Suspicion of infection, including acute fever and complaints of pain and/or stiffness post operatively 3. Revision shoulder surgery for patients described in (1) 4. Provide consent Exclusion Criteria: 1. signs or symptoms of bacteremia or sepsis requiring urgent treatment, which would preclude the possibility of synovial biopsy 2. Unable to speak or read English/French 3. Psychiatric illness that precludes informed consent |
Country | Name | City | State |
---|---|---|---|
Canada | St. Joseph's Health Care London | London | Ontario |
Canada | Sacré-Coeur Hospital of Montreal | Montréal | Quebec |
Canada | The Ottawa Hospital | Ottawa | Ontario |
Canada | Sunnybrook Health Sciences Centre | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
Ottawa Hospital Research Institute |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Rates of Re-Infection | Participants will be monitored for re-infection after their revision surgery for 5-years. Higher incidences of infection indicate a worse outcome. | Post-Operatively up to 5 years. | |
Other | Constant Score | The Constant Score reflects an overall clinical functional assessment. This instrument is based on a 100-point scoring system. Subjective findings (pain, activities of daily living, and working in different positions) make up a total of 35 points. Objective measurements make up the remaining 65 points.The test is divided into four sub-categories: (1) pain is measured using 4 likert levels (15 points maximum), where a higher score indicates a better outcome; activities of daily living are measured using a likert scale, where a higher number indicates better outcomes (20 points maximum); mobility is measured by an assessor, and rated using a likert scale where a higher score indicates better outcomes (40 points maximum); finally, strength is measured by an assessor where 1 point is given per 0.5kg of force (maximum 25 points), a higher score indicates better outcomes. All categories are added together, and a total score out of 100 is given (higher score indicates better outcome). | Post-operatively up to 5-years. | |
Other | Western Ontario Osteoarthritis of the Shoulder (WOOS) | The Western Ontario Osteoarthritis of the Shoulder Index (WOOS) is a disease specific evaluation, proven to be an accurate and valid assessment of function after shoulder replacement. The WOOS is a patient-reported measure, 19-question survey. Each question is measured using a visual analog scale rated from 0-100, where higher scores mean better outcome. | Post-operatively up to 5-years. | |
Other | American Shoulder and Elbow Surgeons (ASES) | The ASES is a shoulder specific assessment divided into two sections: pain and activities of daily living (ADL). Pain is recorded on a visual analogue scale (0-10), lower scores indicate better outcomes. There are 10 activities of daily living questions, each are recorded on a 4 level likert scale (0-3), which a higher score indicates a better outcome. The overall score is an equal weight of the two sections and produces a score out of 100. The higher the score, the better the outcome. | Post-operatively up to 5-years. | |
Other | EQ-5D-5L | The EQ-5D-5L quality of life questionnaire is a brief, easy to administer generic health status questionnaire, consisting of five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) each of which can take one of five responses (each question rated 1-5), lower scores indicate better outcome. It also includes a visual analogue scale for recording an individual's rating of their current health-related quality of life (scale 0 to 100), where a higher score indicates a better outcome. | Post-operatively up to 5-years. | |
Primary | Synovial Biopsy (test diagnostic) and Open Biopsy (reference standard) | To assess the diagnostic accuracy of percutaneous synovial biopsy (test procedure) for detection of implant-related intraarticular shoulder infections (IISI), in comparison to direct macroscopic synovial biopsy, from either arthroscopic or open procedures (the reference standard).
To address the primary objective, standard diagnostic accuracy statistics (sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratio) will be derived, comparing lab results from percutaneous synovial biopsy specimen collection to those of the reference standard test (open/arthroscopic). |
Pre-operatively. | |
Secondary | Reported Pain | Using a visual analog scale, participants will rank their pain level 24-hours after the synovial biopsy. 0 indicating no pain, and 10 indicating the worst pain. A higher score indicates a worse outcome. | 24-hours after biopsy. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05900427 -
Effects on Postoperative Pain of Liposomal Bupivacaine in Interscalene Blocks for Total Shoulder Arthroplasty Patients
|
Phase 4 | |
Completed |
NCT01430468 -
Patient Specific Instruments Versus Standard Surgical Instruments
|
N/A | |
Completed |
NCT03730597 -
Glenosphere Size and Scapular Notch in RSA, Prospective Randomized Study
|
N/A | |
Completed |
NCT01782872 -
Analgesia After Total Shoulder Arthroplasty
|
Phase 4 | |
Completed |
NCT06109415 -
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.
|
Phase 4 | |
Active, not recruiting |
NCT03623269 -
Posterior Approach to Total Shoulder Arthroplasty
|
||
Terminated |
NCT03219983 -
Pain Management After Total Shoulder Arthroplasty
|
Phase 4 | |
Completed |
NCT01726972 -
A Retrospective Review of FloSeal Use in Total Shoulder Arthroplasty
|
||
Enrolling by invitation |
NCT06133933 -
Total Shoulder Arthroplasty Preoperative Pain Threshold and Association With Postoperative Opioid Consumption
|
||
Completed |
NCT04855019 -
Post Surgical Pain in Arthroscopic Shoulder
|
N/A | |
Suspended |
NCT04416932 -
Ultrasound After Total Shoulder Arthroplasty
|
||
Recruiting |
NCT06143306 -
Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement
|
Phase 4 | |
Completed |
NCT03887650 -
LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs
|
Phase 4 | |
Recruiting |
NCT05068960 -
Postoperative Pain Control in Total Shoulder Arthroplasty
|
Phase 4 | |
Completed |
NCT01550952 -
Interscalene Dynamometer Pilot Study
|
N/A | |
Completed |
NCT03969875 -
Comparison of Analgesic Efficacy Between of Interscalene Block With Liposomal Bupivacaine With Bupivacaine and Dexamethasone
|
||
Completed |
NCT04364867 -
Exparel for Total Shoulder Arthroplasty
|
Phase 4 |